English translation of content medically reviewed in Romanian by Dr. Claudiu Ruscu, intensive care physician (anaesthesia & intensive care)· Romanian text reviewed 20 September 2026
300RON
Consultation included if you go ahead · otherwise 200 RON
or message us on WhatsAppCertified doctors · Payment at the clinic
High-dose intravenous vitamin C — an antioxidant that supports the immune system and collagen production.
Available at the clinic or at home in Bucharest & Ilfov. See all prices.

The indication is decided at the medical assessment, based on your history, test results and goals. The doctor tells you whether this protocol is right for you.
The full list of contraindications is discussed during the consultation.
Vitamin C 5 g
The dose is adjusted individually, based on the medical consultation. Every substance is pharmaceutical grade, given intravenously for higher bioavailability.
We assess your health and decide whether this protocol is right for you.
You are seated comfortably. The IV cannula is placed and monitoring begins.
The infusion is given slowly, under medical monitoring, for optimal tolerability.
Afterwards, we check how you are feeling. You can leave straight away.
The high dose of vitamin C usually takes 40-60 minutes, given slowly, under medical supervision.
The frequency is decided at your consultation. Many protocols involve a series of sessions followed by maintenance — the decision is made after your assessment, not according to a standard schedule.
Usually you won't feel anything in particular during the drip, apart from the small prick when the cannula goes in. Most people go back to their usual activities straight away. You are monitored throughout.
The contraindications include G6PD deficiency, oxalate kidney stones, severe kidney failure, pregnancy and breastfeeding. That is why a medical assessment and, sometimes, blood tests are needed beforehand.
300 RON, medical assessment included. Available at the clinic or at home in Bucharest and Ilfov, with transparent pricing.
English translation of answers medically reviewed in Romanian. They do not replace a consultation — indications and contraindications are decided individually, at the medical assessment.
The studies below support the statements on mechanism, pharmacokinetics and safety on this page. They do not support a guaranteed therapeutic outcome — each one is followed by its limitation.
[1] Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004.
case series · sample: 17 · PMID 15068981
Limitation: Healthy hospitalised volunteers. Only doses of up to 1.25 g were measured; the values for higher doses, including 5 g, are estimated by a model, not measured. The study has no clinical outcome: it shows concentrations, not a benefit.
[2] Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A. 1996.
case series · sample: 7 · PMID 8623000
Limitation: Only 7 young, healthy men, hospitalised for 4–6 months on a diet without vitamin C. The study is of the oral route. Tissue saturation at low doses also shows that, in a person without a deficiency, it has not been demonstrated what a high IV dose adds.
[3] Padayatty SJ, Sun AY, Chen Q, et al. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One. 2010.
observational study · sample: 9328 · PMID 20628650
Limitation: The data are self-reported by complementary medicine practitioners: 199 of 550 responded, with a risk of under-reporting. The average dose was 28 g, more than 5 times the 5 g protocol, and the real number of patients is uncertain.
[4] Juneja D, Jain R, Nasa P Vitamin C-induced Hemolysis: Meta-summary and Review of Literature. Indian J Crit Care Med. 2022.
case series · sample: 14 · PMID 35712748
Limitation: 14 case reports, so it is not possible to estimate how common haemolysis is. There is publication bias, and the doses and settings (including critically ill patients) vary widely. It shows that the risk exists, not how large it is at 5 g.
[5] Robitaille L, Mamer OA, Miller WH Jr, et al. Oxalic acid excretion after intravenous ascorbic acid administration. Metabolism. 2009.
case series · PMID 19154961
Limitation: A phase I study in cancer patients with normal kidney function, with doses 3 to 20 times above 5 g and urine collected for only 6 hours. It does not measure the risk in people with kidney disease, which is exactly the group for whom the page asks for caution.
[6] Hemilä H, Chalker E Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013.
meta-analysis · sample: 11306 · PMID 23440782
Limitation: All included studies used oral vitamin C: the intravenous route was not assessed. The 8% shorter duration with regular use qualifies the categorical wording “does not treat”. In people under extreme physical exertion, the risk of a cold was halved.
[7] EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Vitamin C and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA J. 2015.
narrative review · PMID 42169835
Limitation: It is a regulatory opinion on DIETARY intake (the wording “contributes to the normal function”), and the 2015 application concerned children aged 0–3. It says nothing about benefits of high intravenous doses in people without a deficiency.
Indications, studies and frequently asked questions: the complete guide to High-dose vitamin C 5000 mg.
300 RON · consultation included if you go ahead
We use necessary cookies and, only with your consent, analytics and marketing cookies.We use cookies to improve your experience on this site. Strictly necessary cookies are always on. You can also accept analytics and marketing cookies, or decline them. Details